1. Home
  2. IMAX vs WVE Comparison

IMAX vs WVE Comparison

Compare IMAX & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imax Corporation

IMAX

Imax Corporation

HOLD

Current Price

$35.78

Market Cap

2.1B

Sector

N/A

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.30

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMAX
WVE
Founded
1967
2012
Country
Canada
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
IMAX
WVE
Price
$35.78
$7.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
16
Target Price
$44.50
$29.81
AVG Volume (30 Days)
1.1M
3.6M
Earning Date
04-30-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
31.25
N/A
EPS
0.07
N/A
Revenue
$410,212,000.00
$3,704,000.00
Revenue This Year
$9.79
N/A
Revenue Next Year
$7.51
$85.67
P/E Ratio
$511.86
N/A
Revenue Growth
16.47
149.43
52 Week Low
$24.20
$5.02
52 Week High
$43.16
$21.73

Technical Indicators

Market Signals
Indicator
IMAX
WVE
Relative Strength Index (RSI) 42.24 41.79
Support Level $33.64 $6.81
Resistance Level $37.52 $7.67
Average True Range (ATR) 1.50 0.36
MACD -0.07 0.19
Stochastic Oscillator 36.77 54.32

Price Performance

Historical Comparison
IMAX
WVE

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: